Mayu Sugai

The new IASLC grading system for invasive non‐mucinous lung adenocarcinoma is a more useful indicator of patient survival compared with previous grading systems

Naoki Yanagawa, Mayu Sugai, Shunsuke Shikanai et al. · Journal of Surgical Oncology · 2022 · 25 citations

Medicine, Oncology, Pathology +17

Treatment with immune checkpoint inhibitors after <scp>EGFR‐TKIs</scp> in <scp><i>EGFR</i></scp>‐mutated lung cancer

Takashi Ito, Hiromi Nagashima, Masachika Akiyama et al. · Thoracic Cancer · 2021 · 17 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

High expression of fibroblast‐activating protein is a prognostic marker in non‐small cell lung carcinoma

Naoki Yanagawa, Mayu Sugai, Shunsuke Shikanai et al. · Thoracic Cancer · 2022 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +16

Correlation of tumor microenvironment-related markers with clinical outcomes in patients with squamous cell carcinoma of the lung

Mayu Sugai, Naoki Yanagawa, Shunsuke Shikanai et al. · Translational Lung Cancer Research · 2022 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +17

Desmoplastic reactions and epithelial-mesenchymal transition proteins in stages II and III colorectal cancer: association with and prognostic value for disease-free survival

Mai Hashimoto, Noriyuki Uesugi, Mayu Sugai et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2022 · 13 citations

Medicine, Oncology, Pathology +17